Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivityShow others and affiliations
2023 (English)In: Frontiers in Neuroscience, ISSN 1662-4548, E-ISSN 1662-453X, Vol. 17, article id 1175575
Article in journal (Refereed) Published
Abstract [en]
Psychedelic substances have in recent years attracted considerable interest as potential treatments for several psychiatric conditions, including depression, anxiety, and addiction. Imaging studies in humans point to a number of possible mechanisms underlying the acute effects of psychedelics, including changes in neuronal firing rates and excitability as well as alterations in functional connectivity between various brain nodes. In addition, animal studies using invasive recordings, have suggested synchronous high-frequency oscillations involving several brain regions as another key feature of the psychedelic brain state. To better understand how the imaging data might be related to high-resolution electrophysiological measurements, we have here analyzed the aperiodic part of the local field potential (LFP) in rodents treated with a classic psychedelic (LSD) or a dissociative anesthetic (ketamine). In addition, functional connectivity, as quantified by mutual information measures in the LFP time series, has been assessed with in and between different structures. Our data suggest that the altered brain states of LSD and ketamine are caused by different underlying mechanisms, where LFP power shifts indicate increased neuronal activity but reduced connectivity following ketamine, while LSD also leads to reduced connectivity but without an accompanying change in LFP broadband power.
Place, publisher, year, edition, pages
Frontiers Media S.A., 2023. Vol. 17, article id 1175575
Keywords [en]
dissociative anesthetics, in vivo, LFP, neurophysiology, psychedelics
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:umu:diva-209887DOI: 10.3389/fnins.2023.1175575ISI: 001000628000001PubMedID: 37287794Scopus ID: 2-s2.0-85160999924OAI: oai:DiVA.org:umu-209887DiVA, id: diva2:1768288
Funder
The Kempe FoundationsUmeå UniversityOlle Engkvists stiftelsePromobilia foundationStiftelsen Sigurd och Elsa Goljes minneParkinsonfondenHedlund foundationWenner-Gren FoundationsThe Crafoord FoundationSwedish Society for Medical Research (SSMF)The Swedish Brain FoundationSwedish Research Council, 2016−07213Swedish Research Council, 2018-02717Swedish Research Council, 2021-01769Åhlén-stiftelsenMagnus Bergvall FoundationSwedish Childhood Cancer FoundationThorsten and Elsa Segerfalk Foundation2023-06-152023-06-152023-06-15Bibliographically approved